ASCO Chief Medical Officer Dr. Richard L. Schilsky Honored with Award in Gastrointestinal Cancers

Nov 27, 2018

ASCO’s chief medical officer Richard L. Schilsky, MD, FACP, FASCO, is among the five gastrointestinal (GI) oncology professionals honored with OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancers’ 2018 Luminary Awards in GI Cancers.

“The Luminary Awards serve to acknowledge the lifetime contributions made by truly special, dedicated, visionary individuals. Our current successes in GI cancer would not be possible without the work of these remarkable people,” said John Marshall, MD, director of The Ruesch Center for the Cure of Gastrointestinal Cancers.

The group of honorees is comprised of clinicians, researchers, patients, and advocates. Each one has made significant contributions throughout their career to improving care for patients and families who are affected by GI cancers.

Robert Goldsmith, Vice President of OncLive® said, “This [award] not only recognizes the five outstanding individuals, it also honors all of the unacknowledged heroes in the GI cancers community. Each of these winners helps propel the field of GI cancer through their dedicated work and passion for improving the lives of those impacted by gastrointestinal cancer.”

Dr. Schilsky has been the senior vice president and chief medical officer of ASCO since 2013. Formerly the chief of Hematology/Oncology in the Department of Medicine and deputy director of the University of Chicago Comprehensive Cancer Center, he is a highly respected leader in the field of clinical oncology. He specializes in new drug development and treatment of GI cancers. Dr. Schilsky is a past president of ASCO, having served in the role during 2008-2009, and also a past chair of a National Cancer Institute Cooperative Group, Cancer and Leukemia Group B (CALGB).

OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancers will formally recognized this year’s honorees at a reception in Washington, DC, on November 29.

Back to Top